Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Similar documents
Hypertension (JNC-8)

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Difficult to Treat Hypertension

Section 3, Lecture 2

Jared Moore, MD, FACP

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

What in the World is Functional Medicine?

What s In the New Hypertension Guidelines?

Management of Hypertension

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Managing Hypertension in 2016

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Preventing and Treating High Blood Pressure

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

ADVANCES IN MANAGEMENT OF HYPERTENSION

ADVANCES IN MANAGEMENT OF HYPERTENSION

Hypertension Management - Summary

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Antihypertensives. Diagnostic category

Adult Blood Pressure Clinician Guide June 2018

RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

만성콩팥병환자에서의혈압관리 분당서울대병원신장내과 안신영

Management of High Blood Pressure in Adults

Antihypertensive Agents

Modern Management of Hypertension

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension. Most important public health problem in developed countries

Hypertension Update Background

Approach to patient with hypertension. Dr. Amitesh Aggarwal

Pharmacologic Management of Hypertension

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Modern Management of Hypertension: Where Do We Draw the Line?

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment

Hypertension Update. Aaron J. Friedberg, MD

2014 HYPERTENSION GUIDELINES

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

HYPERTENSION IN EMERGENCY MEDICINE Michael Jay Bresler, M.D., FACEP

Hypertension Pharmacotherapy: A Practical Approach

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Heart Failure Clinician Guide JANUARY 2018

Introduction. Factors affecting blood pressure: 1-COP = HR X SV mainly affect SBP. 2-TPR = diameter of arterioles X viscosity of blood affect DBP

hypertension Head of prevention and control of CVD disease office Ministry of heath

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

We are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Network Hypertension Algorithm

Creative blood pressure management: whys and the tricks

Guide to the New Hypertension Guidelines. LCDR J. Garrett Sims, PharmD, BCPS Crow/Northern Cheyenne Hospital

Antihypertensive drugs: I. Thiazide and other diuretics:

New Hypertension Guidelines. Kofi Osei, MD

Guide to the New Hypertension Guidelines

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Hypertension Management: Making Sense of Guidelines and Therapy Options for the Elderly

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

sympatholytics sympatholytics sympatholytics

Combination Therapy for Hypertension

By Prof. Khaled El-Rabat

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Hypertension and the 2017 Guidelines Meeting the Targets in Small Groups. Lisa Ivy APRN

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

ANTI- HYPERTENSIVE AGENTS

Dr Narender Goel MD (Internal Medicine and Nephrology) Financial Disclosure: None, Conflict of Interest: None

Treating Hypertension from

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Hypertension 2015: Recent Evidence that Will Change Your Practice

Approach to Management of Hypertension. Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc

INDIAN HYPERTENSION GUIDELINES-II

Combining Antihypertensives in People with Diabetes

Getting BP to goal: Virginia L. Hood MB.BS, MPH, FACP

HYPERTENSION. Background for understanding the Hypertension literature. Case presentation. Approach to Treatment. Jeffrey J. Kaufhold, MD Nephrology

Heart Failure Clinician Guide JANUARY 2016

4/3/2018 PHARMACOLOGICAL MANAGEMENT OF HYPERTENSION IN THE PATIENT WITH CKD TONI A. HARPS, APRN-CNS, MSN NEPHROLOGY WHY THIS TOPIC/OBJECTIVES

Managing Hypertension in Diabetes Sean Stewart, PharmD, BCPS, BCACP, CLS Internal Medicine Park Nicollet Clinic St Louis Park.

SAURIN GANDHI, AZCOM Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8)

Treatment of Essential Hypertension

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

Pre-ALLHAT Drug Use. Diuretics. ß-Blockers. ACE Inhibitors. CCBs. Year. % of Treated Patients on Medication. CCBs. Beta Blockers.

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Hypertension Update 2009

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Prof. Ramzy H. El Mawardy. Cairo Egypt 2009

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Hypertension in the Era of ACC/AHA: Practice Changing Evidence and Recommendations

HYPERTENSION IN THE ELDERLY A BALANCED APPROACH. Barry Goldlist October 31, 2014

How to Manage Resistant Hypertension Min Su Hyon, MD

Update in Hypertension

Transcription:

Hypertension Update Beverly J. Mathis, D.O. OOA May 2015 Objectives Learn new recommendations for BP treatment goals Approach to hypertension in the office Use of hypertensive drugs, and how to tailor their use to your patient. Hypertension most common office visit in US, (nonpregnant) Up to 30% of adults have hypertension 1

Historical perspective First Joint National Commission report was in 1974 giving education and guidelines on hypertension. 10 years later, the incidence of stroke went down 50% and cardiovascular disease went down 25%. JNC 8 Released in JAMA 2014 Evidence based approach based on randomized control trials Strict so 75% of literature from 1966-2009 was not included 2

Graded A: Strong substantial benefit B: Moderate recommendation C: Weak D: Against recommendation E: Expert opinion Recommendations 1-3 1) Age over 60 with a BP >150/90 Grade A If BP lower than 150/90 and tolerated by do not need additional adjustment. Grade E 2) Age 35-59 BP goal of 90 Diastolic Grade A BP goal of 140 systolic Grade E 3) Age 18-29 BP goal of <140/90 Grade E Recommendation 4 4) CKD >18 to keep BP 140/90 Grade E (CKD defined as GFR <60, Albuminuria >30mg) Exception: Pts with >3g of proteinuria BP of 130/80 (kidney outcome only) No recommendation for age >70. No data. 3

Recommendation 5 5) Diabetes for age >19 BP of 140/90 Grade E ADA recommended this first. Recommendation 6 6) Non black population including diabetics. Grade B Initial therapy with thiazide type diuretic, then calcium channel blocker, and then ACEi or ARB Recommendation 7 7) Black populations Initial treatment with thiazide diuretic or CCB. Grade B Black patients with Diabetes ACE or ARB Grade C 4

Recommendation 8 8) Patient >18 with CKD Initial or additional treatment should be with an ACEi or ARB Grade B Includes diabetics and non-diabetics Direct renin inhibitors not include. NO beneficial studies for kidney or CV outcome. Recommendation 9 9) If BP goal not reached in 1 month: Increase dose of initial drug or add second drug. Grade E Uncontrolled on 2 or more drugs and a referral may be indicated. Grade E 5

Evaluation of patient with hypertension Good history and physical CMP Urinalysis, presence of protein is very important Lipid profile EKG or echo can be helpful Risk factors for hypertension Age Obesity Family history Race CKD, DM, hyperlipidemia High sodium intake, alcohol intake Physical activity 6

Contributing causes of hypertension Glucocorticosteroids, oral contraceptive drugs, especially higher estrogen NSAIDS!!!!!! And decongestants Antidepressants with Norepinephrine, ie, effexor Weight loss meds Stimulants,ie, ritalin Contributing causes of hypertension II Cocaine and meth Primary aldosteronism Renovascular hypertension Obstructive sleep apnea Pheochromocytoma, Cushing, Hypo and hyperthyroidism Primary hyperparathyroidism 7

Does it matter what drug you use? There is no uniform agreement as to which antihypertensive drugs should be given as initial treatment. The American Heart Assoc and the 2013 European society of Hypertension and Cardiology all concluded that the amount of BP reduction is the major determinant of the reduction of cardiovascular risk, not the drug. (Unless they have another reason to take a certain drug) Thiazides 1)Chlorthalidone (12.5-25mg/day) More effective at lowering BP, longer lasting and more 1.5x more potent. More Potassium losses. Hydrocholorothiazide On more formularies and in combinations. Both decrease urinary calcium excretion and are advantageous in osteoporosis. Disadvantages to Thiazides Hypokalemia, hypomagnesemia and hyperuricemia Dehydration Orthostasis Aggravation of gout. 8

Calcium Channel Blockers Dihydropyridines (Amlodipine, Nifedipine) Vasodilating. Helpful in heart failure and patients with orthostasis from autonomic neuropathy. Non dihydrophyridines (Diltiazem, Verapamil) Lowers heart rate. Useful in patients with reactive airway disease and co-existing tachyarrhythmias Disadvantages of a CCB Dihydropyridines- due to vasodilator effects can cause edema. Non dihydropyridines- Can cause bradycardia and constipation. ACE Inhibitors Good for about everyone except Pregnant women Women of child bearing age who might become pregnant Patients who tend to be hyperkalemic Less effective in blacks but use in DM and CHF Low side effect profile: cough, angioedema 9

Uses of ACE inihibitors Hypertension Heart failure Reducing proteinuria in CKD Reducing hyperfiltration in DM Angiotensin Receptor Blockers Much the same effect but not as many studies Angioedema but not cough can cross over Losartan increases uric acid excretion so useful in pts with gout. Beta Blockers Not recommended for first line therapy Indicated in tachycardias, angina, post MI and CHF Useful in migraine Carvedilol and metoprolol most studied in heart disease, atenolol in hypertension 10

Disadvantages of beta blockers Bradycardia Depression Glucose intolerance Bronchoconstriction Should not be used in patients on cocaine Alpha blockers i.e.doxasosin Not indicated as initial therapy unless patient has urinary outlet or prostate problems. Should not be given with Viagra, etc. Slight increase in CV risk if given alone Central alpha agonists Only useful in the acute setting and prn Side effects of dry mouth and sedation limit is use chronically i.e. pt would benefit from sedation. Alpha methyl dopa still most studied drug in pregnancy 11

Vasodilators Hydralazine should always be given with beta blocker to prevent tachycardia Shown to improve mortality in Class II CHFand more efficacious in blacks when mixed with nitrates. Has to be given tid or qid in hypertension Minoxidil, strongest BP med, causes hirsuitism and fluid retention. Should reserve for patients on high doses of at least 3 drugs 12